A33 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of A33 antibodies, specifically designed to target the A33 protein, a cell surface glycoprotein primarily expressed in the gastrointestinal tract. A33 antibodies support research exploring A33's role in cell adhesion, tumorigenesis, and its potential as a therapeutic target in colorectal cancer. A33 antibodies are compatible with various techniques, including western blotting (WB), immunohistochemistry with paraffin-embedded sections (IHCP), immunofluorescence (IF), immunoprecipitation (IP), and flow cytometry (FCM), making them versatile for in vitro studies. The A33 protein is known for its involvement in maintaining epithelial integrity and has been implicated in the progression of certain cancers, highlighting its significance in cancer research and diagnostics. A33 antibodies enable researchers to study the molecular mechanisms underlying A33's function and its potential as a biomarker or therapeutic target. Researchers can use A33 antibodies to examine protein expression patterns in different tissue types. Understanding A33's distribution and regulation helps advance knowledge in cancer biology and potential treatment strategies. A33 antibodies support investigations into cellular signaling pathways and protein-protein interactions. Scientists can leverage A33 antibodies to explore novel therapeutic approaches in gastrointestinal cancer research. A33 antibodies contribute to the ongoing development of targeted cancer therapies and diagnostic tools.